Navigation Links
Published Study Concludes: Vented Baby Bottles Protect Essential Nutrients in Breast Milk and Formula
Date:12/13/2010

ST. LOUIS, Dec. 13, 2010 /PRNewswire/ -- A recently published University of Nevada study indicates that both breast milk and infant formula should be protected from the air to reduce the impact of oxidation on essential nutrients, including vitamins A and E.  An earlier phase of the study showed similar impacts on Vitamin C.  

The study, "Decreasing retinol and [alpha]-tocopherol concentrations in human milk and infant formula using varied bottle systems," has been published in the Journal of Maternal and Child Nutrition. It shows that milk and formula should be handled with care and that choice of bottles can make a difference in baby's nutrition.  In the study, vented bottles such as Dr. Brown's maintained nutrients better than several other common bottles.

The research went beyond traditional concerns about keeping milk and formula fresh to examine the nutritional impacts of air exposure and time.  Vitamin A and E occur naturally in breast milk and are added to formula – both are essential for proper growth and development in children.

The study compared undisturbed breast milk and formula against the same contents in top-selling baby bottles.  An electric pump was used to simulate baby's suckling for the test.  The undisturbed samples and the Dr. Brown's bottles were shown to have the least oxidation and, subsequently, the least rapid loss of nutrients.

The patented vent in the Dr. Brown's bottle prevents air from passing through the breast milk or formula during feeding. Less air and fewer bubbles create less oxidation. The manufacturer of Dr. Brown's bottles funded the study, which was conducted in an academic research setting and its findings peer reviewed by two separate journals. "We are absolutely devoted to making the best possible bottle for babies," said Carolyn Hentschell, Dr. Brown's pre
'/>"/>

SOURCE Dr. Brown's Natural Flow Baby Bottles
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. XIAFLEX® CORD II Study Published in The Journal of Hand Surgery
2. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
3. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
4. New Study Published: Lactobacillus reuteri Prodentis Effective in the Treatment of Periodontitis
5. Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer
6. Study Published This Week in Alzheimers & Dementia: The Journal of the Alzheimers Association Shows that Algal DHA Improved Memory and Learning in Healthy Adults Age 55 and Older
7. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
8. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
9. New Study Published in Journal of Drugs in Dermatology Finds Artefill Effective in Treating Atrophic Acne Scars
10. Ground Breaking Findings on Understanding Cancer Published in the Current Issue of Science
11. Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Texas--(BUSINESS WIRE)--Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) ... of Proellex(TM), an oral drug being developed to,relieve ... with Proellex results in a statistically highly,significant improvement ... well tolerated., Study Details and Results , This ...
... Arrowhead Research,Corporation (NASDAQ: ARWR) announced the publication ... a study,demonstrating the anti-proliferative effect of the ... its lead anti-cancer,compound, CALAA-01., The paper, entitled ... Reduce Cell Proliferation In vitro and In,vivo", ...
Cached Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
(Date:4/18/2014)... Ky. (April 21, 2014) -- A group of ... Medicine and the Sanders-Brown Center on Aging has ... depression and neuropsychological function in Parkinson,s disease (PD). ... Research , the study, which assessed cognitive function ... that the dopamine replacement therapy commonly used to ...
(Date:4/18/2014)... of Medicine researchers have been awarded two-year grants for ... announced this month. Of the 110 initial submissions to ... Forum Program, only four projects were funded, three of ... Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; and ... professor of oncology, will use his $500,000 proof of ...
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2
... , , SACRAMENTO, Calif., July 21 If ... should be aware of California,s laws on pet safety. The California Veterinary ... safe. , , "There are a lot ... of the CVMA. "By taking a few precautions, travel with your companion pets ...
... , ST. LOUIS, July 21 Young ... of Directors declared a quarterly dividend of $0.04 per share, payable September ... Board of Directors also authorized the repurchase of up to 500,000 shares ... 2010 replaces the current authorization which is scheduled to expire on July ...
... , OAKLAND, Calif., July 21 ... owned by Tenet Healthcare Corporation organized an unprecedented national protest ... , , Tenet healthcare workers ... Association (NNOC/CNA) and Service Employees International Union (SEIU) Healthcare leafleted ...
... HIV transmission to infants via pre-chewed food suggest ... also a need for more data , ... have uncovered the first cases in which HIV almost certainly was transmitted from ... in the pre-chewed food was most likely the infected blood in the saliva ...
... right, exercised lowered chances of cardiovascular trouble , TUESDAY, July ... the right foods, exercising and losing weight pay off in ... show. , The reports, both originating at Brigham and Women,s ... of the Journal of the American Medical Association , ...
... , LANSING, Mich., July 21 The ... rushed timeline to address health care reform and urged Michigan,s ... and priorities. , , ... to work with Congress and the President to reform the ...
Cached Medicine News:Health News:Tips for Transporting Your Pet in California 2Health News:Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 2Health News:Tenet Nurses, Healthcare Workers Take Action to Protest Sick Leave Cuts 2Health News:Pre-chewed Food Could Transmit HIV 2Health News:Pre-chewed Food Could Transmit HIV 3Health News:Pre-chewed Food Could Transmit HIV 4Health News:Studies Affirm Value of Healthy Lifestyle 2Health News:Studies Affirm Value of Healthy Lifestyle 3Health News:Michigan Chamber of Commerce Raises Concerns With Flawed Federal Health Care Reform Proposal, Rushed Timeline 2
Incontinence Pessaries...
Incontinence Dish - Stress Incontinence with mild prolapse. Incontinence Dish with support - Stress Incontinence with mild prolapse and mild cystocele...
The donut pessary is designed for third degree prolapse as well as cystocele and rectocele. The soft donut can be compressed for insertion. It is available in seven sizes....
The Incontinence Dish is used to relieve stress incontinence and minor degrees of prolapse. The Incontinence Dish comes with and without support. It is available in eight different sizes....
Medicine Products: